Fresolimumab是一种人源化抗 TGF-β 的单克隆抗体，可以中和所有哺乳动物 TGF-β 的活性亚型， 对 TGF-β2 的结合亲和力为 1.8 nM，能够改善 Bleomycin 诱发的急性肺损伤。Fresolimumab 可用于癌症、脆骨病、纤维化和肾脏疾病等研究。

Purity:SDS-PAGE

Anti-TGFb1 Reference Antibody (fresolimumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.

Purity:SEC-HPLC

The purity of Anti-TGFb1 Reference Antibody (fresolimumab) is 97.38%, determined by SEC-HPLC.

Bioactivity:ELISA

Immobilized human Latent TGF beta 1/TGFB 1, His Tag at 2 ug/mL can bind Anti-TGFb1 Reference Antibody (fresolimumab), EC50=0.06648 ug/mL.

-25~-15℃保存，有效期1年。